747
-1.06%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About EUCALIA
Its shares trade on Tokyo Stock Exchange under the ticker 286A.T. It has been listed since 12 December 2024. In the fiscal year to 31 December 2025, it reported revenue of ¥24.73bn and net income of ¥2.78bn. At that date it held total assets of ¥65.13bn and shareholders' equity of ¥20.52bn.
EUCALIA Inc is a JP-based company operating in industry. The company is headquartered in Chiyoda-Ku, Tokyo-To. The company went IPO on 2024-12-12. EUCALIA Inc is a Japan-based company mainly engaged in healthcare-related businesses. The company operates through three segments. The Medical Management Comprehensive Support Business segment provides comprehensive support for issues faced by affiliated medical corporations, including management consulting, personnel recruitment support, digital transformation (DX) support, and fundraising support. The Senior Related Business segment provides nursing care services such as the operation of nursing care facilities, as well as consultation on admission to nursing care facilities and facility introduction services. The Highly Controlled Medical Device Business segment manufactures and sells contact lenses. The company also provides treatment progress data analysis and sales activity support services for pharmaceutical companies. Through its subsidiaries, it is also engaged in venture investment, as well as the provision of brain checkup services, and real estate buying and selling services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 12 Dec 2024
- Employees
- 812
- Website
- eucalia.jp ↗
Leadership
Pay as last reported
- Mr. Jun FurukawaChief Executive Officer, Founder, Representative Director, since 2005
- Mr. Hideo MisawaChief Director of Corporate Planning, Director, since 2022
- Mr. Yoshikazu NishimuraDirector, since 2022
- Mr. Kyuichi NaneIndependent Director
- Mr. Shuji SutouIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- EUCALIA Inc has a clear operational structure with three distinct business segments.
- The company employs 812 full-time employees, indicating a substantial workforce.
- EUCALIA Inc is engaged in healthcare-related businesses with a focus on medical management and senior care.
Weaknesses
- The company's sector and industry are listed as N/A, indicating a lack of clear industry classification.
- The IPO date is set for 2024-12-12, which is in the future, suggesting it is not yet publicly traded.
- The company's website is provided but no specific details about the site's functionality or content are given.
Opportunities
- The company's involvement in healthcare-related businesses presents opportunities in a growing industry.
- The provision of digital transformation (DX) support and data analysis services could attract more clients.
- The expansion into venture investment and real estate services may diversify revenue streams.
Threats
- The company's future IPO date may create uncertainty for investors and stakeholders.
- The lack of clear industry classification could hinder market positioning and competitive analysis.
- The company's reliance on healthcare-related businesses may expose it to regulatory changes in the healthcare sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.